Schmidt Götz, Rienas Gerrit, Müller Sabrina, Edinger Fabian, Sander Michael, Koch Christian, Henrich Michael
Department of Anesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University Giessen, Giessen, Germany.
Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine, Vidia St. Vincentius-Clinic Karlsruhe gAG, Karlsruhe, Germany.
Front Pharmacol. 2023 Aug 16;14:1155930. doi: 10.3389/fphar.2023.1155930. eCollection 2023.
Mucociliary clearance is a pivotal physiological mechanism that protects the lung by ridding the lower airways of pollution and colonization by pathogens, thereby preventing infections. The fixed 20:1 combination of cafedrine and theodrenaline has been used to treat perioperative hypotension or hypotensive states due to emergency situations since the 1960s. Because mucociliary clearance is impaired during mechanical ventilation and critical illness, the present study aimed to evaluate the influence of cafedrine/theodrenaline on mucociliary clearance. The particle transport velocity (PTV) of murine trachea preparations was measured as a surrogate for mucociliary clearance under the influence of cafedrine/theodrenaline, cafedrine alone, and theodrenaline alone. Inhibitory substances were applied to elucidate relevant signal transduction cascades. All three applications of the combination of cafedrine/theodrenaline, cafedrine alone, or theodrenaline alone induced a sharp increase in PTV in a concentration-dependent manner with median effective concentrations of 0.46 µM (consisting of 9.6 µM cafedrine and 0.46 µM theodrenaline), 408 and 4 μM, respectively. The signal transduction cascades were similar for the effects of both cafedrine and theodrenaline at the murine respiratory epithelium. While PTV remained at its baseline value after non-selective inhibition of β-adrenergic receptors and selective inhibition of β receptors, cafedrine/theodrenaline, cafedrine alone, or theodrenaline alone increased PTV despite the inhibition of the protein kinase A. However, IP receptor activation was found to be the pivotal mechanism leading to the increase in murine PTV, which was abolished when IP receptors were inhibited. Depleting intracellular calcium stores with caffeine confirmed calcium as another crucial messenger altering the PTV after the application of cafedrine/theodrenaline. Cafedrine/theodrenaline, cafedrine alone, and theodrenaline alone exert their effects via IP receptor-associated calcium release that is ultimately triggered by β-adrenergic receptor stimulation. Synergistic effects at the β-adrenergic receptor are highly relevant to alter the PTV of the respiratory epithelium at clinically relevant concentrations. Further investigations are needed to assess the value of cafedrine/theodrenaline-mediated alterations in mucociliary function in clinical practice.
黏液纤毛清除是一种关键的生理机制,通过清除下呼吸道的污染物和病原体定植来保护肺部,从而预防感染。自20世纪60年代以来,卡非君和茶丙喘宁的固定20:1组合一直用于治疗围手术期低血压或因紧急情况导致的低血压状态。由于机械通气和危重病期间黏液纤毛清除功能受损,本研究旨在评估卡非君/茶丙喘宁对黏液纤毛清除的影响。在卡非君/茶丙喘宁、单独的卡非君和单独的茶丙喘宁的影响下,测量小鼠气管制剂的颗粒运输速度(PTV)作为黏液纤毛清除的替代指标。应用抑制性物质以阐明相关的信号转导级联反应。卡非君/茶丙喘宁组合、单独的卡非君或单独的茶丙喘宁的所有三种应用均以浓度依赖性方式导致PTV急剧增加,中位有效浓度分别为0.46 μM(由9.6 μM卡非君和0.46 μM茶丙喘宁组成)、408 μM和4 μM。在小鼠呼吸道上皮,卡非君和茶丙喘宁的作用的信号转导级联反应相似。虽然在非选择性抑制β-肾上腺素能受体和选择性抑制β受体后PTV保持在基线值,但尽管蛋白激酶A受到抑制,卡非君/茶丙喘宁、单独的卡非君或单独的茶丙喘宁仍增加了PTV。然而,发现IP受体激活是导致小鼠PTV增加的关键机制,当IP受体被抑制时,该机制被消除。用咖啡因耗尽细胞内钙储存证实钙是应用卡非君/茶丙喘宁后改变PTV的另一个关键信使。卡非君/茶丙喘宁、单独的卡非君和单独的茶丙喘宁通过IP受体相关的钙释放发挥作用,最终由β-肾上腺素能受体刺激触发。β-肾上腺素能受体处的协同作用与在临床相关浓度下改变呼吸道上皮的PTV高度相关。需要进一步研究以评估卡非君/茶丙喘宁介导的黏液纤毛功能改变在临床实践中的价值。